SYR-472 Open-label Study
NCT01751360
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
14
Enrollment
INDUSTRY
Sponsor class
Conditions
Diabetes Mellitus
Interventions
DRUG:
SYR-472
Sponsor
Takeda